Scientific Ethics and Gene Edited Babies
By Françoise Baylis,
The Boston Globe
| 01. 05. 2020
Three babies, three scientists, three years in jail, and a three million yuan fine. This is the story of He Jiankui and the world’s first genome edited babies.
In November 2018, on the eve of the Second International Summit on Human Genome editing in Hong Kong, news leaked that a Chinese scientist had created genome-edited twins using CRISPR technology, which allows scientists to remove, add, or alter DNA. The news that genetically modified embryos had been used to create the twins was confirmed by He in a YouTube video and a follow-up presentation at the Hong Kong Summit. He explained that he had modified the CCR5 gene to provide the infants with resistance to HIV. During the Q&A period following his presentation, He confirmed that there was another ongoing pregnancy.
He’s experiment was widely condemned on both scientific and ethical grounds. In China, scientists insisted the research was premature. They also feared this controversial experiment would tarnish their scientific reputation for having failed to take ethics seriously. Over a hundred Chinese scientists signed a letter condemning the CRISPR baby experiment...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...